Dubai - AGBL Egypt has announced the first full SARS-CoV2 sequencing in Egypt. The successful sequencing of the virus was performed at the National Research Center (NRC) using an NGS sequencing technology solution supplied and supported by AGBL Egypt.

Mr. Amro Negm, Country Sales Manager at AGBL Egypt, said, “We’re proud to be a part of the first full SARS-CoV2 sequence in Egypt. The AGBL Egypt team has been working selflessly to make sure we support our partners in their diagnostic and research efforts to combat the virus.”

-Ends- 

About AGBL Egypt

AGBL Egypt is a member of the AGBL group of companies, the largest biomedical distribution group in the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centers in emerging healthcare markets. AGBL Egypt is headquartered in Cairo and covers Egypt and Sudan.

www.agbl.net 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.